We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$9.63B
AUM Growth
+$514M
Cap. Flow
-$223M
Cap. Flow %
-2.32%
Top 10 Hldgs %
52.93%
Holding
102
New
30
Increased
20
Reduced
19
Closed
21

Top Buys

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$676M
2
BCR
CR Bard Inc.
BCR
+$435M
3
MBLY
Mobileye N.V.
MBLY
+$254M
4
NXPI icon
NXP Semiconductors
NXPI
+$163M
5
HUN icon
Huntsman Corp
HUN
+$134M

Top Sells

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$463M
2
BEAV
B/E Aerospace Inc
BEAV
+$322M
3
MJN
Mead Johnson Nutrition Company
MJN
+$319M
4
WWAV
The WhiteWave Foods Company
WWAV
+$205M
5
LLY icon
Eli Lilly
LLY
+$134M

Sector Composition

Rank Sector Weight
1 Technology 25.12%
2 Communication Services 21.9%
3 Healthcare 12.59%
4 Industrials 5.7%
5 Consumer Discretionary 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRFS
51
Grifois
GRFS
$5.55B
$22.8M 0.24%
1,079,874
– –
AKAO
52
DELISTED
Achaogen Inc
AKAO
$20.6M 0.21%
948,500
+131,000
+16% +$2.99M
AZN icon
53
AstraZeneca
AZN
$269B
$19.6M 0.2%
287,500
-288,750
-50% -$18.9M
PBYI icon
54
Puma Biotechnology
PBYI
$398M
$18.6M 0.19%
213,000
-367,500
-63% -$20.6M
SHPG
55
DELISTED
Shire pic
SHPG
$17.9M 0.19%
+108,500
New +$19M
NVET
56
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$17.7M 0.18%
2,648,696
– –
ALNY icon
57
Alnylam Pharmaceuticals
ALNY
$38.3B
$16M 0.17%
+200,000
New +$12.8M
H icon
58
Hyatt Hotels
H
$17.5B
$14.9M 0.15%
265,000
-349,000
-57% -$19.8M
PTLA
59
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$14M 0.15%
+250,000
New +$10M
SVRA icon
60
Savara
SVRA
$1.08B
$13.1M 0.14%
+2,225,000
New +$15.3M
RXDX
61
DELISTED
Ignyta, Inc.
RXDX
$11.9M 0.12%
+1,153,500
New +$9.37M
STML
62
DELISTED
Stemline Therapeutics, Inc.
STML
$10.6M 0.11%
1,157,500
-10,000
-0.9% -$83.4K
AKBA icon
63
Akebia Therapeutics
AKBA
$338M
$10.5M 0.11%
+730,000
New +$9.25M
WGL
64
DELISTED
Wgl Holdings
WGL
$10M 0.1%
+120,000
New +$9.95M
KATE
65
DELISTED
Kate Spade & Company
KATE
$9.8M 0.1%
530,000
+320,000
+152% +$5.9M
TGNA
66
DELISTED
TEGNA Inc
TGNA
$9.65M 0.1%
+670,000
New +$10.3M
HZNP
67
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$8.84M 0.09%
745,000
-1,650,000
-69% -$20.5M
SAGE
68
DELISTED
Sage Therapeutics
SAGE
$7.96M 0.08%
+100,000
New +$7.23M
CYOU
69
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$6.23M 0.06%
+160,812
New +$5.52M
AMRN
70
Amarin Corp
AMRN
$297M
$6.03M 0.06%
74,750
– –
PCO
71
DELISTED
Pendrell Corporation - Class A
PCO
$5.94M 0.06%
8,211
– –
BKD icon
72
Brookdale Senior Living
BKD
$3.55B
$4.85M 0.05%
+330,000
New +$4.56M
QCOM icon
73
Qualcomm
QCOM
$164B
$4.69M 0.05%
+85,000
New +$4.75M
IMGN
74
DELISTED
Immunogen Inc
IMGN
$3.59M 0.04%
+505,000
New +$2.31M
GCVRZ
75
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.6M 0.03%
6,827,805
– –
1 2
3
4

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Farallon Capital Management held 102 positions worth $9.63B, up 5.6% from $9.11B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Farallon Capital Management's Q2 2017 filing shows 30 new, 20 increased, 19 reduced and 21 closed positions. Its largest new stake was Altaba Inc: 12,427,457 shares worth $677M. The largest sale was Yahoo Inc, an estimated $463M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Communication Services and Healthcare.

  • Farallon Capital Management's largest Q2 2017 buy was Altaba Inc: 12,427,457 shares worth $677M.
  • Farallon Capital Management added most to Mobileye N.V. in Q2 2017, an estimated $254M increase.
  • Farallon Capital Management's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $98.7M.
  • Farallon Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $463M.
  • Farallon Capital Management's ten largest holdings make up 53% of its $9.63B portfolio in Q2 2017.
  • Farallon Capital Management opened 30 new positions and closed 21 in Q2 2017.
  • Farallon Capital Management's portfolio value rose 5.6% quarter-over-quarter to $9.63B.

Based on Farallon Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.